Association between the molecular markers, effect and time of response to the androgen-deprivation therapy in patients with prostate cancer

by L. V. Spirina, A. K. Gorbunov, I. V. Kondakova, E. A. Usynin, E. M. Slonimskaya
Published 2019-04-01

TRANSCRIPTION FACTOR BRN-3α AND PROSTATE CANCER, RELATION WITH HORMONE RECEPTORS AND AKT/M-TOR SIGNALING PATHWAY ACTIVATION

by L. V. Spirina, A. K. Gorbunov, I. V. Kondakova, E. M. Slonimskaya, E. A. Usynin
Published 2018-03-01

ROLE OF NEUREGULINS AND HEPATOCYTE GROWTH FACTOR IN THE DEVELOPMENT OF CASTRATION-RESISTANT PROSTATE CANCER

by L. V. Spirina, E. A. Usynin, E. M. Slonimskaya, I. V. Kondakova, A. K. Gorbunov
Published 2016-02-01

THE ROLE OF GROWTH AND TRANSCRIPTION FACTORS IN EVALUATING THE EFFECTIVENESS OF NEOADYUVANTNOY CHEMOTHERAPY IN PATIENTS WITH MUSCLE-INVASIVE BLADDER CANCER

by E. A. Usynin, L. V. Spirinа, E. M Slonimskaya, I. V. Kondakova, E. G. Grigoriev, A. K. Gorbunov
Published 2016-12-01